Vertebral fracture prevalence among women screened for the fracture intervention trial and a simple clinical tool to screen for undiagnosed vertebral fractures

被引:69
作者
Vogt, TM
Ross, PD
Palermo, L
Musliner, T
Genant, HK
Black, D
Thompson, DE
机构
[1] Kaiser Permanente Ctr Hlth Res, Honolulu, HI 96819 USA
[2] Merck Res Labs, Rahway, NJ USA
[3] Univ Calif San Francisco, San Francisco, CA 94143 USA
[4] Merck & Co Inc, Whitehouse Stn, NJ 08889 USA
关键词
D O I
10.4065/75.9.888
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To evaluate the ability of self-reported risk factors to identify postmenopausal women likely to have extant vertebral fractures because approximately two thirds of women with radiographic evidence of vertebral fracture are unaware of the fracture. Patients and Methods: Questionnaire and spinal radiographic data were collected from postmenopausal women with a femoral neck bone mineral density T score of -1.6 or lower during screening for the Fracture Intervention Trial. Logistic regression was used to identify risk factors for extant vertebral fractures and to derive a final multivariable model, Results: Almost two thirds of 25,816 women 55 years and older met the bone density criterion, and 21% of those had an extant vertebral fracture. The final model consisted of 5 self-reported items: history of vertebral fracture, history of nonvertebral fracture, age, height loss, and diagnosis of osteoporosis. These were combined to yield a Prevalent Vertebral Fracture Index (PVFI), The prevalence of women with vertebral fracture varied from 3.8% to 62.3% over the range PVFI of 0 to greater than 5, Among the 13,051 women screened with spinal radiographs, a PVFI of 4 or greater identified 65.5% of women with vertebral fractures (sensitivity), with a specificity of 68.6%. Excluding 881 women who reported prior vertebral fractures reduced the sensitivity to 53.6% and increased the specificity to 70.7% but did not alter the fracture prevalence at PVFI values less than 6, Conclusion: In this population, 5 simple questions identified women who were likely to have undiagnosed vertebral fractures. Further research is needed to determine the validity of this index in other populations, including women without low bone mineral density.
引用
收藏
页码:888 / 896
页数:9
相关论文
共 35 条
[1]  
BLACK DM, 1993, OSTEOPOROSIS INT, V3, pS29
[2]  
BLACK DM, 1995, J BONE MINER RES, V10, P890
[3]   Prevalent vertebral deformities predict hip fractures and new vertebral deformities but not wrist fractures [J].
Black, DM ;
Arden, NK ;
Palermo, L ;
Pearson, J ;
Cummings, SR .
JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 (05) :821-828
[4]   Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures [J].
Black, DM ;
Cummings, SR ;
Karpf, DB ;
Cauley, JA ;
Thompson, DE ;
Nevitt, MC ;
Bauer, DC ;
Genant, HK ;
Haskell, WL ;
Marcus, R ;
Ott, SM ;
Torner, JC ;
Quandt, SA ;
Reiss, TF ;
Ensrud, KE .
LANCET, 1996, 348 (9041) :1535-1541
[5]   INCIDENCE OF CLINICALLY DIAGNOSED VERTEBRAL FRACTURES - A POPULATION-BASED STUDY IN ROCHESTER, MINNESOTA, 1985-1989 [J].
COOPER, C ;
ATKINSON, EJ ;
OFALLON, WM ;
MELTON, LJ .
JOURNAL OF BONE AND MINERAL RESEARCH, 1992, 7 (02) :221-227
[6]   Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures - Results from the fracture intervention trial [J].
Cummings, SR ;
Black, DM ;
Thompson, DE ;
Applegate, WB ;
Barrett-Connor, E ;
Musliner, TA ;
Palermo, L ;
Prineas, R ;
Rubin, SM ;
Scott, JC ;
Vogt, T ;
Wallace, R ;
Yates, AJ ;
LaCroix, AZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (24) :2077-2082
[7]   RISK-FACTORS FOR HIP FRACTURE IN WHITE WOMEN [J].
CUMMINGS, SR ;
NEVITT, MC ;
BROWNER, WS ;
STONE, K ;
FOX, KM ;
ENSRUD, KE ;
CAULEY, JC ;
BLACK, D ;
VOGT, TM .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (12) :767-773
[8]   Managing osteoporosis in older people with fractures - Needs to be taken as seriously as coronary artery disease [J].
Doube, A .
BRITISH MEDICAL JOURNAL, 1999, 318 (7182) :477-478
[9]   Treatment with alendronate prevents fractures in women at highest risk - Results from the fracture intervention trial [J].
Ensrud, KE ;
Black, DM ;
Palermo, L ;
Bauer, DC ;
BarrettConnor, E ;
Quandt, SA ;
Thompson, DE ;
Karpf, DB .
ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (22) :2617-2624
[10]   THE PREDICTIVE VALUE OF FRACTURE, DISEASE, AND FALLING TENDENCY FOR FRAGILITY FRACTURES IN WOMEN [J].
GARDSELL, P ;
JOHNELL, O ;
NILSSON, BE ;
NILSSON, JA .
CALCIFIED TISSUE INTERNATIONAL, 1989, 45 (06) :327-330